Anti-FK-506 [Clone FK1]
£366.56
Anti-FK-506 [Clone FK1] (17301-250ug)
Product
| Cat # 17301-250ug | Size 250 µg |
Price
£366.56
|
Qty
|
Description
FK-506 is a novel macrolide with similar, but more potent, immunosuppressant activity than cyclosporine. FK-506 is used for primary or rescue immunosuppression in patients after solid organ transplantation. Clinically relevant side effects of FK-506 administration are nephrotoxicity, neurotoxicity, diabetes mellitus, and hypertension. Most of these side effects are related to blood levels of FK-506 rather than dosage. Therefore, therapeutic drug monitoring of FK-506 is a prerequisite for therapy. The whole blood target level range aimed for in clinical practice is 3.0-20.0 ng/ml and depends on the patient's liver function, the nature of organ transplantation, and the time after transplantation.
Specifications
| Manufacturer | Leinco Technologies Inc |
|---|---|
| Manufacturer Cat# | 17301 |
| Product Size | 250 µg |
| Concentration | Lot Specific |
| Formulation | PBS containing 0.1% sodium azide |
| Clone | FK1 |
| Target | FK-506 |
| Applications | ELISA, WB |
| Storage | This antibody is stable for at least one (1) year at -20°C. Avoid multiple freeze- thaw cycles. |